Replies to post #164376 on Biotech Values

[DewDiligence]

HTBX is down 9% from its recent IPO price, a rarity in this biotech market.

[DewDiligence]

Bearish sign for HTBX—underwriters exercised only 27% (100K/375K) of the 30-day overallotment option; these options are almost always exercise in full:

http://finance.yahoo.com/news/heat-biologics-inc-announces-partial-154353673.html